Sign in
4

Changes in Ownership

Guardant Health, Inc. Filed Acc 0001753159-26-000014

Co-Chief Executive Officer sold 260,000 shares at an average $151.20 ($39,312,654)

  • Co-Chief Executive Officer acquired 254,832 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Talasaz AmirAli · Co-Chief Executive Officer

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-26 Exercise or conversion : show line 1 in the form 10b5-1 +111,804 $4.18 $467,341 1,998,308 I
2026-06-26 Sale : show line 2 in the form 10b5-1 −64,037 $150.49 $9,636,838 1,934,271 I
2026-06-26 Sale : show line 3 in the form 10b5-1 −52,935 $151.16 $8,001,628 1,881,336 I
2026-06-29 Exercise or conversion : show line 4 in the form 10b5-1 +143,028 $4.18 $597,857 2,024,364 I
2026-06-29 Sale : show line 5 in the form 10b5-1 −25,812 $150.53 $3,885,434 1,998,552 I
2026-06-29 Sale : show line 6 in the form 10b5-1 −70,513 $151.47 $10,680,315 1,928,039 I
2026-06-29 Sale : show line 7 in the form 10b5-1 −46,663 $152.20 $7,102,319 1,881,376 I
2026-06-29 Sale : show line 8 in the form 10b5-1 −40 $153.00 $6,120 1,881,336 I
Open-market sales · 260,000 sh · avg $151.20 · $39,312,654

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-06-26 Exercise or conversion : show line 9 in the form 10b5-1 Stock Option (Right to Buy) −111,804 172,025 D
2026-06-29 Exercise or conversion : show line 10 in the form 10b5-1 Stock Option (Right to Buy) −143,028 28,997 D
Loading xslF345X06/wk-form4_1782854022.xml…